Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief

Seungkyu Lee1

  • 1F. M. Kirby Neurobiology Center, Children's Hospital Boston, Boston MA 02115 USA; ; Department of Neurobiology, Harvard Medical School, Boston MA 02115 USA.

Insights

Voltage-gated calcium channels (VGCCs) are crucial in pain signaling. Targeting specific VGCC subtypes offers a promising avenue for developing novel, effective chronic pain therapeutics with fewer side effects.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Chronic pain presents a significant therapeutic challenge due to current treatment limitations, including low efficacy and adverse effects.
  • Voltage-gated calcium channels (VGCCs), composed of various subunits, are integral to pain signaling pathways, influencing neurogenic inflammation, neuronal excitability, and neurotransmitter release in nociceptors.
  • N-type VGCCs (Cav2.2) are established pain targets, evidenced by FDA-approved drugs like gabapentin, pregabalin, and ziconotide.

Purpose of the Study:

  • To review existing VGCC subtype inhibitors and explore their potential as targets for novel chronic pain therapeutics.
  • To highlight the emerging roles of L-type (Cav1.2) and T-type (Cav3.2) VGCCs in pain signaling.
  • To emphasize the necessity of developing subtype-selective VGCC inhibitors or targeted delivery methods for nociceptors.

Main Methods:

  • Literature review of studies investigating VGCCs in pain signaling.
  • Analysis of current and potential therapeutic strategies targeting VGCC subtypes.
  • Discussion of the role of different VGCC subtypes (Cav2.2, Cav1.2, Cav3.2) in chronic pain mechanisms.

Main Results:

  • N-type VGCCs (Cav2.2) are validated targets for chronic pain management.
  • Evidence suggests L-type (Cav1.2) and T-type (Cav3.2) VGCCs also contribute to pain signaling.
  • Subtype-selective inhibition and targeted delivery are key for advancing VGCC-based pain therapies.

Conclusions:

  • Developing subtype-selective VGCC inhibitors is essential for advancing chronic pain treatment.
  • Targeting specific VGCCs in nociceptors can lead to a new class of analgesics.
  • Further research into VGCC subtypes will improve understanding of spinal pain mechanisms and therapeutic development.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
2.1K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.3K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
11.2K
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.4K